Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Yu, San Diego

Baofa Yu, San Diego, CA US

Patent application numberDescriptionPublished
20100104660COMPOSITION AND METHOD FOR TREATING TUMOR - Methods for treating neoplasm, tumors and cancers, using one or more tumor treating drug carriers, haptens and anticancer drugs, alone or in combination with other antineoplastic agents or treatments, are provided. Also provided are compositions, and kits containing the composition for affecting the therapy.04-29-2010

Cheng Zhi Yu, San Diego, CA US

Patent application numberDescriptionPublished
20080275100PROPOFOL ANALOGS, PROCESS FOR THEIR PREPARATION, AND METHODS OF USE - The invention provides para substituted dialkylphenol derivatives of propofol. The invention further provides pharmaceutical compositions comprising such analogs, methods for preparing such analogs, and methods of using such analogs to induce general anesthesia, sedation, and/or hypnotic or sleep effects in a patient.11-06-2008
20090130163Drugs With Improved Hydrophobicity For Incorporation in Medical Devices - The invention provides a medical device comprising a hydrophobic analog of a medicament known to inhibit cell proliferation and migration. The invention also provides a method of treating a narrowing in a body passageway comprising placing an implantable medical device comprising a hydrophobic analog of a medicament known to inhibit cell proliferation and migration. The medicaments can be incorporated within or coated on the device. The invention further provides hydrophobic analogs of medicaments known to inhibit cell proliferation and migration.05-21-2009
20100160448COMPOSITIONS, METHODS OF USE AND PREPARATION OF 2,6-DIISOPROPYL PHENOL AND ANALOGS FOR ISCHEMIC INJURY - The present invention provides novel 2,6-diisopropyl phenol 2,6-diisopropyl phenol analogs and sterile, stable pharmaceutical compositions of 2,6-diisopropyl phenol 2,6-diisopropyl phenol and analogs thereof useful as an antioxidant in the treatment of ischemic injury including stroke and other cerebral injury. 2,6-diisopropyl phenol or its analogs are administered in a dosage effective to produce blood levels and brain levels of the drug that can prevent free radical damage associated with ischemic injury.06-24-2010
20100305148DI-ESTER PRODRUGS OF CAMPTOTHECIN, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL APPLICATIONS - The present invention is related to 10,20-di-O ester derivatives of camptothecin and pharmaceutical formulations thereof. The compounds and pharmaceutical formulations of the present invention possess increased biological life span and bioavailability and reduced toxicity, while maintaining anti-cancer activity.12-02-2010

Patent applications by Cheng Zhi Yu, San Diego, CA US

Dehua Yu, San Diego, CA US

Patent application numberDescriptionPublished
20080281105Novel Quinolinium Salts and Derivatives - The present invention relates generally to the synthesis of novel quinolinium salts and derivative compounds. Such salts and compounds are useful for inhibiting the growth of cancer cells.11-13-2008

Edward T. Yu, San Diego, CA US

Patent application numberDescriptionPublished
20090250110FORWARD SCATTERING NANOPARTICLE ENHANCEMENT METHOD AND PHOTO DETECTOR DEVICE - In devices of the invention, forward scattering nanoparticles are sized and arranged with respect to a photo conversion material to forward scatter radiation that would otherwise be reflected away from the photo conversion material. In preferred embodiment devices, a highest percentage of the nanoparticles are sized such that their predominant characteristic is scattering as opposed to absorption. The nanoparticles forward scatter radiation into the photo conversion material that would otherwise be reflected. In preferred embodiments, the nanoparticles are metal nanoparticles, such as gold, silver, copper, or aluminum nanoparticles, and in other embodiments the nanoparticles are dielectric nanoparticles, e.g., silica, sized to predominately forward scatter radiation.10-08-2009

Fuqu Yu, San Diego, CA US

Patent application numberDescriptionPublished
20090075360APPARATUS AND METHODS FOR MANIPULATION AND OPTIMIZATION OF BIOLOGICAL SYSTEMS - The invention provides systems and methods for manipulating, e.g., optimizing and controlling, biological systems, e.g., for eliciting a more desired biological response of biological sample, such as a tissue, organ, and/or a cell. In one aspect, systems and methods of the invention operate by efficiently searching through a large parametric space of stimuli and system parameters to manipulate, control, and optimize the response of biological samples sustained in the system, e.g., a bioreactor. In alternative aspects, systems include a device for sustaining cells or tissue samples, one or more actuators for stimulating the samples via biochemical, electromagnetic, thermal, mechanical, and/or optical stimulation, one or more sensors for measuring a biological response signal of the samples resulting from the stimulation of the sample. In one aspect, the systems and methods of the invention use at least one optimization algorithm to modify the actuator's control inputs for stimulation, responsive to the sensor's output of response signals. The compositions and methods of the invention can be used, e.g., to for systems optimization of any biological manufacturing or experimental system, e.g., bioreactors for proteins, e.g., therapeutic proteins, polypeptides or peptides for vaccines, and the like, small molecules (e.g., antibiotics), polysaccharides, lipids, and the like. Another use of the apparatus and methods includes combination drug therapy, e.g. optimal drug cocktail, directed cell proliferations and differentiations, e.g. in tissue engineering, e.g. neural progenitor cells differentiation, and discovery of key parameters in complex biological systems.03-19-2009

Haihui Yu, San Diego, CA US

Patent application numberDescriptionPublished
20110288122Pharmaceutical Compositions and Administrations Thereof - The present invention relates to the use of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, solids forms, and pharmaceutical compositions thereof for the treatment of CFTR mediated diseases, particularly cystic fibrosis, in patients possessing specific genetic mutations.11-24-2011

Jack X. Yu, San Diego, CA US

Patent application numberDescriptionPublished
20080305959Laser microdissection and microarray analysis of breast tumors reveal estrogen receptor related genes and pathways - About 70% to 80% of breast cancers express estrogen receptor-α (ERα), and estrogens play important roles in the development and growth of hormone-dependent tumors. Together with lymph node metastasis, tumor size and histological grade, ER status is considered one of the prognostic factors in breast cancer, and an indicator for hormonal treatment. 147 genes and 112 genes with significant P-value and having significant differential expression between ER+ and ER− tumors were identified from the LCM data set and bulk tissue data set, respectively. 61 genes were found to be common in both data sets, while 85 genes were unique to the LCM data set and 51 genes were present only in the bulk tumor data set. Pathway analysis with the 85 genes using Gene Ontology suggested that genes involved in endocytosis, ceramide generation, Ras/ERK/Ark cascade, and JAT-STAT pathway may play roles related to ER. The gene profiling with LCM-captured tumor cells provides a unique approach to characterize and study epithelial tumor cells and to gain an insight into signaling pathways associated with ER.12-11-2008
20090155805COPY NUMBER ALTERATIONS THAT PREDICT METASTATIC CAPABILITY OF HUMAN BREAST CANCER - Disclosed in this specification is a method of defining chromosome regions of prognostic value by summarizing the significance of all SNPs (single nucleotide polymorphism) in a predetermined section of a chromosome to define chromosome regions of prognostic value. Based on the SNPs in specified genes, a more accurate prognosis for breast cancer may be provided.06-18-2009
20110275079DIAGNOSTIC BIOMARKERS OF DIABETES - Methods are disclosed for the identification of gene sets that are differentially expressed in PBMCs of patients diagnosed with a pre-diabetic disease state and overt type II diabetes. 3 gene and 10 gene signatures are shown to accurately predict a diabetic disease state in a patient. The application also described kits for the rapid diagnosis of diabetic disease states in patients at a point of care facility.11-10-2011

Patent applications by Jack X. Yu, San Diego, CA US

Jia Yu, San Diego, CA US

Patent application numberDescriptionPublished
20090045009LINEAR ACOUSTIC LINER - A linear acoustic liner for an aircraft includes a cellular core having a first surface and an opposed second surface. A substantially imperforate back skin covers the first surface, and a perforate face skin covers the second surface of the core. The perforate face skin includes an outer face skin layer having a first plurality of spaced openings, an inner face skin layer having a second plurality of spaced openings, and a porous layer disposed between the outer face skin layer and the inner face skin layer. Each of the first plurality of spaced openings are substantially aligned with one of the second plurality of spaced openings.02-19-2009
20100122868ACOUSTIC BARREL FOR AIRCRAFT ENGINE NACELLE INCLUDING CRACK AND DELAMINATION STOPPERS - An acoustic inner barrel for an aircraft engine nacelle inlet is constructed from a composite material and is formed as a single, 360-degree annular segment. The barrel includes an inner skin, an outer skin, a cellular core disposed between the inner skin and the outer skin, and at least one crack and delamination stopper extending radially from the inner skin to the outer skin.05-20-2010
20110162910LINEAR ACOUSTIC LINER - A linear acoustic liner for an aircraft includes a cellular core having a first surface and an opposed second surface. A substantially imperforate back skin covers the first surface, and a perforate face skin covers the second surface of the core. The perforate face skin includes an outer face skin layer having a first plurality of spaced openings, an inner face skin layer having a second plurality of spaced openings, and a porous layer disposed between the outer face skin layer and the inner face skin layer. Each of the first plurality of spaced openings are substantially aligned with one of the second plurality of spaced openings.07-07-2011
20120291416Crack and Delamination Stoppers For Aircraft Propulsion System Components - An inner fixed structure of a thrust reverser includes an inner skin, an outer skin, a cellular core disposed between the inner skin and the outer skin, and at least one crack and delamination stopper extending radially between the inner skin and the outer skin.11-22-2012

Patent applications by Jia Yu, San Diego, CA US

Jianqiang Yu, San Diego, CA US

Patent application numberDescriptionPublished
20130101607Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR1) Single Chain FV Antibody Fragment Conjugates and Methods of Use Thereof - Compositions including an antibody single-chain variable fragment (scFv) conjugate that specifically binds to ROR1 tumor-associated antigen are provided. The anti-ROR1 scFv antibody and conjugates may include a biologically-active molecule. Such conjugates may comprise a chimeric receptor to direct T cells to respond to ROR1 cancer cells, Methods to use the scFV conjugates to target cells expressing ROR1 for therapeutic and diagnostic purposes are also provided.04-25-2013

Jin-Quan Yu, San Diego, CA US

Patent application numberDescriptionPublished
20120059179PALLADIUM-CATALYZED ORTHO-FLUORINATION - A new method of ortho-fluorination where an aryl C—H bond is directly replaced by an aryl C-F bond in a palladium-catalyzed reaction is provided. The method includes the ortho-fluorination of a triflamide protected benzylamine, a palladium catalyst, such as Pd(OTf)03-08-2012

Julie Yu, San Diego, CA US

Patent application numberDescriptionPublished
20120309345SYSTEM AND METHOD FOR THIRD PARTY APPLICATION SALES AND SERVICES TO WIRELESS DEVICES - A system, method, and computer program for tracking billable events occurring on wireless devices on a wireless network and billing the appropriate parties. The billable events occur from the end-users of the wireless devices selectively communicating with other computer devices across the wireless network and downloading and executing software applications thereupon. The billable event data is ultimately gathered at a server on the wireless network from which billing for the wireless device billable events can be generated.12-06-2012

Lin Yu, San Diego, CA US

Patent application numberDescriptionPublished
20080293660CHEMICALLY-DEFINED NON-POLYMERIC VALENCY PLATFORM MOLECULES AND CONJUGATES THEREOF - Chemically-defined, non-polymeric valency platform molecules and conjugates comprising chemically-defined valency platform molecules and biological or chemical molecules including polynucleotide duplexes of at least 20 base pairs that have significant binding activity for human lupus anti-dsDNA autoantibodies.11-27-2008

Patent applications by Lin Yu, San Diego, CA US

Liwen Yu, San Diego, CA US

Patent application numberDescriptionPublished
20120238279TRANSMISSION POWER COORDINATION FOR SMALL-COVERAGE BASE STATIONS - Coordinating transmission power for small-coverage base stations deployed in a wireless communication network may comprise, for example, receiving a plurality of measurement reports corresponding to two or more base stations, determining a coordinated coverage condition for the base stations, and setting a transmission power for at least one of the base stations based on the measurement reports and the coverage condition.09-20-2012

Naichen Yu, San Diego, CA US

Patent application numberDescriptionPublished
20120295253Dynamic Monitoring of Activation of Receptor Tyrosine Kinase (RTK) in Living Cells Using Real-Time Microelectronic Cell Sensing Technology - Methods for identifying a compound capable of interacting with a Receptor Tyrosine Kinase (RTK) including providing a device capable of measuring cell-substrate impedance, adding test cells expressing a RTK to the device, measuring first impedances, adding a compound to at least one compound well and adding a vehicle control at least one control well, measuring second impedances of the compound well and the control well, determining the change in the impedance for the compound well and the one control well, comparing the change in impedance between the compound well and the control well, and identifying the compound interacts with the RTK if the comparison demonstrates a significant difference between the change in impedance.11-22-2012

Nicholas Yu, San Diego, CA US

Patent application numberDescriptionPublished
20100174661Wireless Branding - A device wirelessly broadcasts branding information associated with a consumer product attached to the device. The branding information is sent to a receiver located remotely from the product.07-08-2010
20100191072Button Sensor - A hermetically sealed electronic closure device, or button, includes a self-renewing power source, a sensor for measuring a metric, a memory storing information, a data processing circuit for controlling operations of the device, and a transceiver for sending and receiving information. The device is a standard part of a clothing item that is inconspicuous to a wearer of the clothing item.07-29-2010
20110273926Method and Apparatus of Probabilistic Programming Multi-Level Memory in Cluster States Of Bi-Stable Elements - A probabilistic programming current is injected into a cluster of bi-stable probabilistic switching elements, the probabilistic programming current having parameters set to result in a less than unity probability of any given bi-stable switching element switching, and a resistance of the cluster of bi-stable switching elements is detected. The probabilistic programming current is injected and the resistance of the cluster state detected until a termination condition is met. Optionally the termination condition is detecting the resistance of the cluster of bi-stable switching elements at a value representing a multi-bit data.11-10-2011

Nicholas K. Yu, San Diego, CA US

Patent application numberDescriptionPublished
20120033490Generating a Non-Reversible State at a Bitcell Having a First Magnetic Tunnel Junction and a Second Magnetic Tunnel Junction - A method of generating a non-reversible state at a bitcell having a first magnetic tunnel junction (MTJ) and a second MTJ includes applying a program voltage to the first MTJ of the bitcell without applying the program voltage to the second MTJ of the bitcell. A memory device includes a bitcell having a first MTJ and a second MTJ and programming circuitry configured to generate a non-reversible state at the bitcell by applying a program signal to a selected one of the first MTJ and the second MTJ of the bitcell.02-09-2012

Paul Kit Lai Yu, San Diego, CA US

Patent application numberDescriptionPublished
20080267565Y-Junction Reflector Tunable Delay or Resonator Waveguide Devices - The invention provides tunable delay or resonator devices in an electro optical substrate. Signals in at least one waveguide in the electro optical substrate pass through Y-junction reflectors which direct signals from one branch of the waveguide back into another branch of the waveguide. A coupled delay or resonator approximated loop is presented in an embodiment of the invention with opposing Y-junction reflectors. In other embodiments of the invention, a delay ladder is provided with selectable levels of delay from multiple outputs.10-30-2008
20110116742COUPLED WAVEGUIDE PHOTO DETECTOR - An embodiment of the invention provides a coupled waveguide photo detector device. Optically, the device includes an input waveguide. An output waveguide is coupled to the input waveguide with a nonuniform coupling coefficient in a coupling section. An absorber is included in the coupling section to convert an absorbed portion of optical radiation into photo current. The location of absorber and the optical radiation intensity pattern in the coupling section are set to control the maximum intensity of output power absorbed by the output waveguide to be within a predetermined limit that avoids saturation. The absorber is also part of a transmission line collector which has a phase and group velocity to match those of the optical wave in the coupling section such that currents collected by the transmission line collector add in phase as the optical wave propagates in the output waveguide.05-19-2011
20110247691OPTICAL SPECTRAL CONCENTRATOR, SENSORS AND OPTICAL ENERGY POWER SYSTEMS - Methods and devices of the invention perform an optical concentration by an expansion of usable spectral width of the incident energy. Preferred methods and devices of the invention concentrate optical energy by tuning it into a narrow spectral width to match the bandgap of another system component, such as an optical fiber, an optical sensor or a photovoltaic device that converts the optical energy. Embodiments of the invention include methods and devices for the spectral concentration of multi-wavelength light and subsequent transport of the concentrated output light.10-13-2011

Qishan Yu, San Diego, CA US

Patent application numberDescriptionPublished
20120087065SHIELDING STRUCTURES FOR WIRELESS ELECTRONIC DEVICES WITH DISPLAYS - Electronic devices such as computers and handheld devices are provided. The electronic devices may have electrical components such as displays that are driven by driver circuitry. During operation, the driver circuitry may generate radio-frequency noise. Communications circuitry in the electronic devices may be shielded from the radio-frequency noise by radio-frequency shielding structures. The shielding structures may be mounted on portions of the display module, on a cover glass layer, or on other structures such as housing structures. The radio-frequency shielding structures may be formed from one or more metal segments. The metal segments may run along edges of the display. A device housing may have a ground formed from a conductive peripheral member that runs around peripheral edges of the housing and a conductive plate that is connected to the conductive peripheral member. The radio-frequency shielding structure may be connected to the ground using conductive structures.04-12-2012

Shiping Yu, San Diego, CA US

Patent application numberDescriptionPublished
20110240263Enhanced Electronic Cooling by an Inner Fin Structure in a Vapor Chamber - A vapor chamber cooling apparatus to cool an electronic component includes a sealed, hollow metal chamber; a working fluid disposed within the metal chamber; a wick structure disposed along an inner surface of the metal chamber; and an inner fin structure disposed within with the metal chamber. An area of the metal chamber is in thermal contact with the electronic component. The inner fin structure is in thermal contact with the metal chamber. A method of manufacturing a vapor chamber cooling apparatus to cool an electronic component includes providing a metal chamber, wherein an area of the metal chamber thermally contacts the electronic component; disposing a wick structure along an inner surface of the metal chamber; disposing a working fluid within the metal chamber; and disposing an inner fin structure within the metal chamber and in thermal contact with the metal chamber.10-06-2011

Wei Hong Yu, San Diego, CA US

Patent application numberDescriptionPublished
20120201809MULTIFUNCTIONAL ANTIBODY CONJUGATES - The present invention relates to Multifunctional Antibody Conjugates, comprising an antibody or antigen binding portion thereof, comprising at least a fragment of a light chain constant kappa region (CLκ) comprising K08-09-2012

Wei-Luen Yu, San Diego, CA US

Patent application numberDescriptionPublished
20120083527Anticancer Agents - The present disclosure relates generally to compositions and methods for treating cancer. In some aspects, novel spirohexenolides and methods of using and producing them are described.04-05-2012

Xiaoyu Yu, San Diego, CA US

Patent application numberDescriptionPublished
20130035551ARTICULATING OPHTHALMIC SURGICAL PROBE - An articulating optical surgical probe includes a handle sized to fit in a single hand and a single rigid cannula extending from the handle having a diameter of 20 Ga or less. The probe further includes a slotted tip at a distal end of the cannula and at least one optical fiber extending through the handle, the single rigid cannula and the slotted tip, and a pull-wire secured to the slotted tip. When the pull-wire exerts tension on the slotted tip, the slotted tip will deviate from straight to a bend angle controlled by the tension in the pull-wire. The slotted tip is formed from a resilient material that will restore to the straight position when the tension exerted by the pull-wire is released.02-07-2013

Xing-Xian Yu, San Diego, CA US

Patent application numberDescriptionPublished
20080255030COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS - The invention provides compositions and methods for the treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a gene encoding a Jun N-terminal kinase 1 (JNK1 protein.10-16-2008
20090054359COMPOSITIONS AND THEIR USES DIRECTED TO DIACYLGLYCEROL ACYLTRANSFERASE 1 - Disclosed herein are compounds, compositions and methods for modulating DGAT-1 activity. Preferably, the expression of DGAT-1 from a nucleic acid is inhibited. Methods are provided for treating, ameliorating or treating liver fibrosis, either directly or by treating an underlying etiological factor. Preferably, the treatment, amelioration or prevention comprises administering a DGAT-1 activity modulator.02-26-2009
20090221671MODULATION OF LMW-PTPASE EXPRESSION - Disclosed herein are compounds, compositions and methods for modulating the expression of LMW-PTPase in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Also provided are methods for the prevention, amelioration and/or treatment of diabetes, insulin resistance, insulin deficiency, hypercholesterolemia, hyperglycemia, dyslipidemia, hyperlipidemia, hypertriglyceridemia, and hyperfattyacidemia. In some embodiments, the diabetes is type II diabetes by administration of antisense compounds targeted to LMW-PTPase.09-03-2009
20100292140ANTISENSE MODULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR 4 EXPRESSION - Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 4 (FGFR4). The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 4. Methods of using these compounds for modulation of fibroblast growth factor receptor 4 expression and for treatment of diseases associated with expression of fibroblast growth factor receptor 4 are provided.11-18-2010
20110123521METHODS FOR MODULATING EXPRESSION OF RBP4 - Methods are provided for modulating RBP4 by administering a RBP4-specific modulator. Also provided are methods for treating cardiovascular and metabolic disorders in a subject or delaying or preventing risk factors thereof through the modulation of RBP4. The present invention is also directed to methods of decreasing lipid levels in a subject or for preventing or delaying the onset of a rise in lipid levels in a subject, comprising administering to said subject a RBP4-specific inhibitor.05-26-2011
20110177097METHODS FOR MODULATING EXPRESSION OF CREB - Methods are provided for modulating CREB by administering a CREB-specific modulator. Also provided are methods for treating cardiovascular and metabolic disorders in a subject or delaying or preventing risk factors thereof through the modulation of CREB. The present invention is also directed to methods of decreasing lipid levels in a subject or for preventing or delaying the onset of a rise in lipid levels in a subject, comprising administering to said subject a CREB-specific inhibitor.07-21-2011
20120029050COMPOSITIONS AND THEIR USES DIRECTED TO DIACYLGLYCEROL ACYLTRANSFERASE 1 - Disclosed herein are compounds, compositions and methods for modulating DGAT-1 activity. Preferably, the expression of DGAT-1 from a nucleic acid is inhibited. Methods are provided for treating, ameliorating or treating liver fibrosis, either directly or by treating an underlying etiological factor. Preferably, the treatment, amelioration or prevention comprises administering a DGAT-1 activity modulator.02-02-2012
20120214736COMPOSITIONS AND METHODS FOR THE MODULATION OF JNK PROTEINS - The invention provides compositions and methods for the treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a gene encoding a Jun N-terminal kinase 1 (JNK1 protein.08-23-2012

Patent applications by Xing-Xian Yu, San Diego, CA US

Xudong Yu, San Diego, CA US

Patent application numberDescriptionPublished
20100083337Multipurpose television module - A method of processing a boot sequence for a processor forming a part of a module apparatus involves interrogating a host television device to determine if the host television device requires use of an application execution engine residing on the module apparatus; receiving a reply to the interrogation; and responsive to the reply, establishing a mode of operation wherein the application execution engine is used to execute application code for the host television device. This abstract is not to be considered limiting, since other embodiments may deviate from the features described in this abstract.04-01-2010
20110113443IP TV With DRM - A method of decrypting DRM encoded content in a DTV receiver involves receiving an encrypted license from a license server at the DTV receiver; providing a unique identifier for an integrated DTV SoC forming a part of the DTV television receiver; storing a secret key in an electronic fuse memory forming a part of the SoC, where the secret key is generated using an algorithm that utilizes the unique identifier for the SoC; where the received encrypted license is encrypted using the same secret key as is stored in the electronic fuse memory; decrypting the secret key using the key stored in the electronic fuse memory to produce a clear secret key; decrypting the encrypted license using the clear secret key to determine a content key; storing the license; and decrypting the DRM encoded content using the content key. This abstract is not to be considered limiting, since other embodiments may deviate from the features described in this abstract.05-12-2011
20120227074ENHANCED INFORMATION FOR VIEWER-SELECTED VIDEO OBJECT - The user of an Internet-enabled CE device such as a TV can select an object in a video presented on the display of the CE device by either touch sensitive screen or input device. The processor of the CE device can then determine the boundaries of the object, identify it using face/image recognition software, search for information/websites related to the object, and present those information/websites to the viewer on the display screen.09-06-2012

Patent applications by Xudong Yu, San Diego, CA US

Yue Yu, San Diego, CA US

Patent application numberDescriptionPublished
20090110066Method and Apparatus for Selecting a Coding Mode - A method and apparatus for selecting a coding mode for a block of a current picture are disclosed. For example, the method selects a coding mode in accordance with a cost function, for coding the block, wherein the cost function comprises a coding distortion parameter and a number of coding bits parameter, wherein said coding distortion parameter is measured in accordance with at least one of: between a prediction residual and a reconstructed prediction residual, or between a transformed prediction residual and a dequantized transformed prediction residual, wherein the number of coding bits parameter is computed in accordance with at least one of: from a true number of compressed bits resulting from coding said block, directly from a plurality of bins, or directly from a plurality of quantized transform coefficients.04-30-2009
20090161757Method and Apparatus for Selecting a Coding Mode for a Block - A method and apparatus for processing an input image are disclosed. For example, the method receives a block of pixels from the input image, and selects a coding mode for the block of pixels based on at least one coding mode of at least one neighbor block of the block of pixels. The method determines whether the coding mode will result in all zero coefficients for the block of pixels, and selects the coding mode for the block of pixels if the coding mode will result in all zero coefficients for the block of pixels.06-25-2009
20110064141Picture Level Adaptive Frame/Field Coding for Digital Video Content - A method and system of encoding and decoding digital video content. The digital video content comprises a stream of pictures which can each be intra, predicted, or bi-predicted pictures. Each of the pictures comprises macroblocks that can be further divided into smaller blocks. The method entails encoding and decoding each picture in said stream of pictures in either frame mode or in field mode.03-17-2011
20120328005CONSTRUCTION OF COMBINED LIST USING TEMPORAL DISTANCE - In one embodiment, a method receives a current picture of video content. The method then determines a set of reference pictures for the current picture and a temporal distance from the current picture for each of the set of reference pictures. A combined list of reference pictures in the set of reference pictures is determined where an order of pictures in the combined list is based on the temporal distance for each of the set of reference pictures to the current picture. The method then uses the combined list to perform temporal prediction for the current picture.12-27-2012
20130016785SPATIAL BLOCK MERGE MODE - In one embodiment, a spatial merge mode for a block of video content may be used in merging motion parameters. Spatial merge parameters are considered and do not require utilization of bits or flags or indexing to signal at the encoder or decoder. If the spatial merge mode is determined, the method merges the block of video content with a spatially-located block, where merging shares motion parameters between the spatially-located block and the block of video content.01-17-2013
20130022117TEMPORAL BLOCK MERGE MODE - In one embodiment, a method includes determining motion parameters for a temporally-located block to a current block of video content. The temporally-located block is located in a different picture from the current block. The temporally-located block is identified in a merge mode candidate list. The merge mode candidate list includes candidate blocks in which motion parameters are candidates to be used for the current block. The method then signals information to a decoder to indicate which motion parameters from a candidate block on the merge mode candidate list to use in decoding the current block. If a temporally-located block is identified, the method uses motion parameters for the temporally-located block in decoding the current block of video content.01-24-2013

Patent applications by Yue Yu, San Diego, CA US

Zhi-Zhong Yu, San Diego, CA US

Patent application numberDescriptionPublished
20100322092METHOD AND APPARATUS FOR SELECTING A RECEIVING APPARATUS FOR CO-CHANNEL OPERATION - A method of selecting a receiving apparatus for co-channel operation, the method comprising: transmitting a first and a second data at predetermined respective power levels on a single first channel comprising a single frequency and time slot; receiving the data; measuring a characteristic of the data; transmitting a signal indicating the measured characteristic; receiving the indicating signal; and responding to the received indicating signal by selecting the receiving apparatus for co-channel operation depending on the measured characteristic.12-23-2010